References for: association

Full identifier: http://purl.org/np/RAivaI9R59azEQYT7xfZPxx8AtXSjgWxIXjuLQbmDvImY#association

Nanopublication Part Subject Predicate Object Published By Published On
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
0000-0002-7641-6446
2021-08-17T13:35:42.767Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
0000-0002-7641-6446
2021-08-17T13:35:42.767Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
0000-0002-7641-6446
2021-08-17T13:35:42.767Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
0000-0002-7641-6446
2021-08-17T13:35:42.767Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
0000-0002-7641-6446
2021-08-17T13:35:42.767Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
0000-0002-7641-6446
2021-08-17T13:35:42.767Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
0000-0002-7641-6446
2021-08-17T13:35:42.767Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Moreover, although the studies were uncontrolled, a significant body of literature has highlighted the potential benefit of clozapine in the treatment of acute mania, the depressive phase of BD, and in overall mood stabilization, with some evidence suggesting its use not only in treatment-resistant schizophrenia but also in treatment-refractory BD.
0000-0002-7641-6446
2021-08-17T13:35:42.767Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
0000-0002-7641-6446
2021-08-17T13:35:42.767Z